Evidence map›Paper›PMID 29505580›Full record

ArticlePLoS neglected tropical diseases2018

Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status.

Mohammed A K Mahdy, Rashad Abdul-Ghani, Thaker A A Abdulrahman, Samira M A Al-Eryani, Abdulsalam M Al-Mekhlafi, Sami A A Alhaidari, Ahmed A Azazy

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Research progress of health care in Yemeni children during the war: review.Primary health care research & development · 2022
    Review
  5. Article
  6. Onchocerciasis Elimination: Progress and Challenges.Research and reports in tropical medicine · 2020
    Review
  7. Onchodermatitis: Where Are We Now?Tropical medicine and infectious disease · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Mohammed A K MahdyTropical Disease Research Center, University of Science and Technology, Sana'a, Yemen.ORCID 0000-0002-8340-5219
Rashad Abdul-GhaniTropical Disease Research Center, University of Science and Technology, Sana'a, Yemen.
Thaker A A AbdulrahmanHealth Services Sector, the Charitable Society for Social Welfare, Sana'a, Yemen.
Samira M A Al-EryaniDepartment of Parasitology, Faculty of Medicine and Health Sciences, Sana'a University, Sana'a, Yemen.
Abdulsalam M Al-MekhlafiDepartment of Parasitology, Faculty of Medicine and Health Sciences, Sana'a University, Sana'a, Yemen.
Sami A A AlhaidariNational Schistosomiasis and Parasites Control Program, Ministry of Public Health and Population, Sana'a, Yemen.
Ahmed A AzazyDepartment of Laboratory Medicine, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha, KSA.
Sana'a University · YEUniversity of Science and Technology · YEAl Baha University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOnchocerciasis in Yemen is one of the most neglected diseases, where baseline estimates of onchocerciasis and monitoring of the impact of ivermectin regularly administered to the affected individuals on its transmission are lacking. Therefore, this study aimed to determine the anti-Ov16 IgG4 seroprevalence among local communities of Hodeidah and Al-Mahwit governorates of Tihama region. The factors possibly associated with previous exposure to infection were also studied. METHODOLOGY/PRINCIPAL

findingsThis cross-sectional study was conducted in two ivermectin-targeted districts endemic for onchocerciasis in Hodeidah and Al-Mahwit and two untargeted districts with unknown previous endemicity in Hodeidah between February and July 2017. For 508 residents sampled by a multi-stage random approach, data were collected and blood specimens were screened for anti-Ov16 IgG4 using the SD BIOLINE Onchocerciasis IgG4 rapid tests. The study revealed an overall anti-Ov16 IgG4 rate of 18.5% (94/508) in all surveyed districts, with 10.2% (12/118) of children aged ≤10 years being seropositive. Moreover, rates of 8.0% (4/50) and 6.1% (4/66) were found in districts not officially listed as endemic for the disease. Multivariable analysis confirmed the age of more than ten years and residing within a large family as the independent predictors of exposure to infection. CONCLUSIONS/SIGNIFICANCE: Onchocerciasis transmission is still ongoing as supported by the higher anti-Ov16 IgG4 seroprevalence rate among children aged ≤10 years compared to that (<0.1%) previously set by the World Health Organization as a serologic criterion for transmission interruption. Further large-scale studies combining serologic and entomologic criteria are recommended for the mapping of O. volvulus in human and blackfly populations in endemic foci and their neighboring areas of uncertain endemicity. In addition, ivermectin distribution, coverage and impact on disease transmission need to be continually assessed.

Indexed as

AdolescentAdultAgedAged, 80 and overAnimalsAntibodies, HelminthChildChild, PreschoolCross-Sectional StudiesEndemic DiseasesFemaleHumansImmunoglobulin GInfantInfant, NewbornInsect VectorsAntibodies, HelminthImmunoglobulin GIvermectin

Identifiers

PMID29505580
PMCPMC5854432
OpenAlexW2793324161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.